%0 Journal Article
%A Earl, Julie
%A Kataki, Agapi
%A Canzian, Federico
%A Costello, Eithne
%A Campa, Daniele
%A Greenhalf, William
%T Targeting pancreatic cancer screening by identification of pathogenic variants of BRCA2/ BRCA1 in healthy individuals who have no known family history of pancreatic cancer: The arguments for and against.
%J Seminars in cancer biology
%V 113
%@ 1044-579X
%C London
%I Academic Press
%M DKFZ-2025-00958
%P 1 - 8
%D 2025
%X The majority of patients with pancreatic ductal adenocarcinoma (PDAC) are no longer suitable for treatment with curable intent at the time of diagnosis resulting in a 5-year survival of less than 10 
%K BRCA1 (Other)
%K BRCA2 (Other)
%K Cancer risk (Other)
%K Germline mutation (Other)
%K Screening (Other)
%K Surveillance (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:40339999
%R 10.1016/j.semcancer.2025.05.001
%U https://inrepo02.dkfz.de/record/301273